SCHEMBL17148959

SCHEMBL17148959

CCOC(=O)c1cc(-c2ccc(F)cc2)nc2c1c(C)nn2Cc1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.59
▸ KDM4E B2RXH2 7/20 0.59
▸ HPGD P15428 7/20 0.59
▸ UBE2N P61088 2/20 0.59
▸ GLA P06280 2/20 0.59
▸ HTT P42858 1/20 0.59
▸ TDP1 Q9NUW8 1/20 0.59
▸ LMNA P02545 1/20 0.58
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ NPSR1 Q6W5P4 3/20 0.57
▸ CYP1A2 P05177 2/20 0.57
▸ CYP2C9 P11712 2/20 0.57
▸ CYP2C19 P33261 2/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ RXFP1 Q9HBX9 1/20 0.56
▸ GAA P10253 1/20 0.55
▸ HSD17B10 Q99714 3/20 0.53
▸ MAPK1 P28482 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17147413 0.97 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDUBE2NGLA
SCHEMBL17148957 0.96 RXFP1 (0.59) ALDH1A1KDM4EHPGDUBE2NGLA
SCHEMBL17148958 0.92 KDM4E (0.51) ALDH1A1KDM4EHPGDUBE2NGLA
SCHEMBL17148956 0.90 KDM4E (0.48) ALDH1A1KDM4EHPGD
SCHEMBL17147436 0.89 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDUBE2NGLA
SCHEMBL17147434 0.89 KDM4E (0.49) ALDH1A1KDM4EHPGDUBE2NGLA
SCHEMBL17148945 0.88 RXFP1 (0.49) ALDH1A1KDM4EHPGDUBE2NGLA
SCHEMBL17147422 0.87 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDLMNASMN1; SMN2
SCHEMBL17148944 0.87 DHODH (0.53) ALDH1A1KDM4EHPGD
SCHEMBL17147407 0.87 KDM4E (0.46) ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3125884-B1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF UNIV MICHIGAN REGENTS (US) 2019-11-06 — — EP disclosed
US-9394303-B2 Small molecule inhibitors of MCL-1 and uses thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-07-19 — — US disclosed
US-20150284387-A1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-10-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284387-A1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF MCL1, BCL2L1, API5 ALDH1A1 1518/4885KDM4E 1138/4885HPGD 3099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback